Immunotherapies and immunomodulatory approaches in clinical trials - a mini review

Immunotherapies and immunomodulatory approaches in clinical trials - a mini review

The coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created havoc worldwide. Due to the non-availability of any vaccine or drugs against COVID-19, immunotherapies involving convalescent plasma, immunoglobulins, antibodies (monocl...

Full description

Bibliographic Details
Main Authors: Mohd. Iqbal Yatoo, Zeenat Hamid, Izhar Rather, Qurat Ul Ain Nazir, Riyaz Ahmed Bhat, Abrar Ul Haq, Suhail Nabi Magray, Zulfqar Haq, Ranjit Sah, Ruchi Tiwari, SenthilKumar Natesan, Muhammad Bilal, Harapan Harapan, Kuldeep Dhama
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
sars-cov-2
covid-19
immunotherapies
immunomodulators
Online Access:http://dx.doi.org/10.1080/21645515.2020.1871295

Internet

http://dx.doi.org/10.1080/21645515.2020.1871295

Similar Items